JPS6245208B2 - - Google Patents

Info

Publication number
JPS6245208B2
JPS6245208B2 JP56120459A JP12045981A JPS6245208B2 JP S6245208 B2 JPS6245208 B2 JP S6245208B2 JP 56120459 A JP56120459 A JP 56120459A JP 12045981 A JP12045981 A JP 12045981A JP S6245208 B2 JPS6245208 B2 JP S6245208B2
Authority
JP
Japan
Prior art keywords
human
cells
necrosis factor
htnf
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56120459A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5821621A (ja
Inventor
Masakazu Mihashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Mochida Pharmaceutical Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP56120459A priority Critical patent/JPS5821621A/ja
Priority to SE8204382A priority patent/SE8204382L/xx
Priority to FR8212541A priority patent/FR2513124B1/fr
Priority to KR8203215A priority patent/KR870001433B1/ko
Priority to IT48855/82A priority patent/IT1196549B/it
Priority to AU86200/82A priority patent/AU560793B2/en
Priority to CH4420/82A priority patent/CH664974A5/fr
Priority to US06/400,487 priority patent/US4495282A/en
Priority to DE3249946A priority patent/DE3249946C2/de
Priority to DE3227262A priority patent/DE3227262C3/de
Priority to ES514210A priority patent/ES514210A0/es
Priority to AT0283582A priority patent/AT387980B/de
Priority to GB08221100A priority patent/GB2106117B/en
Priority to CA000408532A priority patent/CA1213544A/en
Publication of JPS5821621A publication Critical patent/JPS5821621A/ja
Priority to JP62028311A priority patent/JP2518635B2/ja
Priority to JP62028310A priority patent/JP2518634B2/ja
Publication of JPS6245208B2 publication Critical patent/JPS6245208B2/ja
Priority to SE9000532A priority patent/SE9000532L/xx
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56120459A 1981-07-21 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤 Granted JPS5821621A (ja)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP56120459A JPS5821621A (ja) 1981-07-31 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤
SE8204382A SE8204382L (sv) 1981-07-21 1982-07-19 Sett att framstella malcellysfaktor och anvendning derav
FR8212541A FR2513124B1 (fr) 1981-07-21 1982-07-19 Production et applications du facteur de lyse des cellules-cibles
KR8203215A KR870001433B1 (ko) 1981-07-21 1982-07-20 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
IT48855/82A IT1196549B (it) 1981-07-21 1982-07-20 Procedimento per la produzione del fattore di lisi cellule bersaglio (tclf),prodotto ottenuto a suo impiego in terapia clinica,in particolare come agente citolitico antitumurale
AU86200/82A AU560793B2 (en) 1981-07-21 1982-07-20 Production of target cell lysis factor
CH4420/82A CH664974A5 (fr) 1981-07-21 1982-07-20 Production du facteur de lyse des cellules-cibles.
DE3227262A DE3227262C3 (de) 1981-07-21 1982-07-21 Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
DE3249946A DE3249946C2 (de) 1981-07-21 1982-07-21 hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
US06/400,487 US4495282A (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor and uses therewith
ES514210A ES514210A0 (es) 1981-07-21 1982-07-21 Un procedimiento para la produccion de tclf.
AT0283582A AT387980B (de) 1981-07-21 1982-07-21 Verfahren zur herstellung eines die aufloesung menschlicher zellen bewirkenden faktors
GB08221100A GB2106117B (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor
CA000408532A CA1213544A (en) 1981-07-31 1982-07-30 Process for producing target cell lysis factor and uses therewith
JP62028311A JP2518635B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−
JP62028310A JP2518634B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−の製造方法
SE9000532A SE9000532L (sv) 1981-07-21 1990-02-14 Farmaceutisk tclf-komposition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56120459A JPS5821621A (ja) 1981-07-31 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP62028311A Division JP2518635B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−
JP62028310A Division JP2518634B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−の製造方法

Publications (2)

Publication Number Publication Date
JPS5821621A JPS5821621A (ja) 1983-02-08
JPS6245208B2 true JPS6245208B2 (enrdf_load_html_response) 1987-09-25

Family

ID=14786690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56120459A Granted JPS5821621A (ja) 1981-07-21 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤

Country Status (1)

Country Link
JP (1) JPS5821621A (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764744B2 (ja) * 1981-11-21 1995-07-12 株式会社林原生物化学研究所 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
GR851626B (enrdf_load_html_response) * 1984-07-05 1985-11-26 Genentech Inc
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
JPS5816687A (ja) * 1981-07-21 1983-01-31 Hayashibara Biochem Lab Inc リンホトキシンの製造方法
JPS6011890A (ja) * 1983-06-30 1985-01-22 富士通株式会社 イメ−ジメモリ制御方式

Also Published As

Publication number Publication date
JPS5821621A (ja) 1983-02-08

Similar Documents

Publication Publication Date Title
US4285929A (en) Type II interferon and agents thereof
US4495282A (en) Process for producing target cell lysis factor and uses therewith
US4621050A (en) Process for the production of human colony-stimulating factor
DK153848B (da) Fremgangsmaade til fremstilling af interferon
JPS6227048B2 (enrdf_load_html_response)
JPS6245208B2 (enrdf_load_html_response)
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
JP2518634B2 (ja) ヒト ツモア・ネクロシス・フアクタ−の製造方法
JPS5816687A (ja) リンホトキシンの製造方法
JP2926409B2 (ja) 癌転移抑制因子の製造方法
JP2518635B2 (ja) ヒト ツモア・ネクロシス・フアクタ−
US4624917A (en) Process for the production of human T-cell growth factor
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JPH0446928B2 (enrdf_load_html_response)
JPS5823793A (ja) ヒトｔ細胞増殖因子の製造方法
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
JPH0523755B2 (enrdf_load_html_response)
JPH0527640B2 (enrdf_load_html_response)
JPS6045850B2 (ja) ヒト副腎皮質刺激ホルモンの製法
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
JPS61115028A (ja) 抗腫瘍効果増強剤
JPS6323176B2 (enrdf_load_html_response)